Barclays PLC Insulet Corp Call Options Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$180.69 - $239.01 $379,449 - $501,921	-2,100 Reduced 51.22%	2,000 $466,000
Q2 2024 Aug 14, 2024	BUY	$161.02 - $206.98 $322,040 - $413,960	2,000 Added 95.24%	4,100 $827,000
Q4 2023 Feb 15, 2024	BUY	$127.77 - $221.42 $268,317 - $464,982	2,100 New	2,100 $456,000
Q2 2022 Aug 12, 2022	BUY	$186.4 - $279.02 $7.01 Million - $10.5 Million	37,600 New	37,600 $8.19 Million

710

62.7M

640K

841K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $19.2B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.